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INTRODUCTION 
G.V.Black’s statement “An endemic imperfection of the enamel of the teeth 
heretofore unknown in the literature of dentistry” has become well known today in 
dentistry. The term ‘mottled enamel’ and ‘denti di chiaie’ were scientifically coined as 
dental fluorosis by Dean in 1934
1,2 
. Since the time of inception, enormous scientific 
literature on dental fluorosis has been reported, the most well known being ‘shoe 
leather survey’2. However, the studies on dental fluorosis had a paradigm shift when 
an inverse association between dental fluorosis and dental caries was discovered. In 
1942, a important milestone discovery was made by Dean et al, reporting 60% 
reduction in dental caries at 1 ppm of fluoride in drinking water
2
. Fluoridation of 
drinking water is considered as important public health measure for prevention of 
dental caries
2
. Worldwide, dental caries prevalence has been declining due to 
fluoridation of drinking water. However, dental fluorosis is still a public health 
problem posing a major health care burden.  
Dental fluorosis is a developmental defect that occurs due to ingestion of 
excess fluoride during critical periods of tooth development mainly during the first 7 
years of life. It is characterised by white flecks and chalky white appearance of enamel 
mainly in cusp tips (mild dental fluorosis) and  brown stains, mottling  to confluent 
pitting of dental enamel to corroded  appearance of teeth (severe dental fluorosis)
 3,6
.  
Crippling skeletal fluorosis might occur in people who have ingested 10 to 20 
mg of fluoride per day for over 10 to 20 years
3
. Early stages of skeletal fluorosis start 
with pain in bones and joints, muscle weakness, sporadic pain, stiffness of joints and 
chronic fatigue. During later stages, osteosclerosis of pelvis, vertebra, osteoporosis of 
long bones, calcification of ligaments and tendons, genu valgum (knock knees), 
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limitation of joint movement, crippling deformities, compression of spinal cord may 
also lead to paralysis. Skeletal fluorosis leads to impairment, disability and 
subsequently handicap. Therefore, they are unable to get employment or labour for 
their daily basic needs, lead their life as dependents on others
3
.  
Non skeletal manifestations of fluorosis includes neurological manifestations 
like depression, nervousness, headache, gastrointestinal problems, nausea, abdominal 
pain, diarrhoea, blood in stools, muscular manifestations like muscle weakness, pain 
in muscle, allergic manifestations  like  skin rashes, urinary tract manifestations like 
decreased volume of urine, colour change in urine, burning, prickling, and tingling in 
limbs. It also adversely affects the foetal cerebral function and neurotransmitters
1
. 
Fluorosis is an important public health problem in many countries, including 
India, mostly of geological origin. Water with high levels of fluoride content  is 
mostly found at the foot of high mountains and in areas where the sea has made 
geological deposits. Known fluoride belts on land include one that stretches from 
Syria through Jordan, Egypt, Libya, Algeria, Sudan and Kenya, and another that 
stretches from Turkey through Iraq, Iran, Afghanistan, India, northern Thailand and 
China
5
. There are similar belts in the America and Japan. Of the 85 million tons of 
fluoride deposits on the earth’s crust, 12 million are found in India3. The extent of 
fluoride levels of water in India varies from 1.0 to 48.0 mg/l
8
. 
The WHO guideline value for fluoride in water is not universal. The WHO 
guidelines suggested that in areas with a warm climate, the optimal concentration of 
fluoride in drinking water should remain below 1 mg/litre (1ppm or part per million), 
while in cooler climates it could go up to 1.2 mg/litre. The World Health Organization 
and Indian Council of Medical Research described the drinking water quality 
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guideline value for fluoride as 1.5 mg/l (WHO, 1963; ICMR, 1975)
1
. In 1994, World 
Health Organization expert committee on fluoride use stated that 1.0 mg/L should be 
an absolute upper bound, even in cold climates, and that 0.5 mg/L may be an 
appropriate lower limit
6
. 
The first case of endemic skeletal fluorosis in humans from India was reported 
by Short et al. from Prakasam district of Andhra Pradesh in 1937. Subsequently, in 
1950, Andhra Pradesh, Tamil Nadu, Punjab and Uttar Pradesh reported cases of 
fluorosis. A report published by Rajiv Gandhi National Drinking Water Mission in 
2010, identified 17 states in India, and was recorded as endemic for fluorosis
7
. 
According to a recent report, the disease is endemic in about 275 districts of 20 states 
and Union territories, an estimated 62 million people in India are affected with dental, 
skeletal and/or non-skeletal fluorosis
8
. 
According to the National Oral Health survey and Fluoride Mapping of the 
Dental Council of India (2002-2003), the overall prevalence of dental fluorosis is 10% 
which was mostly in the milder form.
 
In fluoride rich districts, however the prevalence 
is as high as 18%
9
. In Tamilnadu the prevalence of dental fluorosis ranged as low as 
17% in the district of Vellore to as high as 36% in the district of Dharmapuri. The 
prevalence of severe form of dental fluorosis was observed to be maximum in the 
districts of Salem and Dharmapuri (3%), followed by Krishnagiri (1.9%), Vellore 
(1.5%) and Erode (0.4%)
 10
. 
Several studies have demonstrated a difference in the prevalence of dental or 
skeletal fluorosis depending on the sex, age and the origin of the population. Previous 
studies in mice and humans, as well as epidemiological studies, have demonstrated 
that severity of dental fluorosis cannot be explained solely by the quantity and amount 
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of fluoride consumption. It has also been shown that there is great variation in severity 
of fluorosis within a given category of estimated fluoride intake. 
There are few studies that show that there is a genetic influence on fluorosis. 
However, most of these studies were done in animal models and extrapolation of these 
results to humans must be done with caution. Overall, these studies suggest that the 
genetic makeup of an individual can play a role in the etiology of dental fluorosis. 
Until recently, very few studies have explored the underlying genetic basis for fluoride 
susceptibility.  
A gene is the basic physical and functional unit of heredity. Genes, which are 
made up of DNA, act as instructions to make molecules called proteins. In humans, 
genes vary in size from a few hundred DNA bases to more than 2 million bases. The 
Human Genome Project has estimated that humans have between 20,000 and 25,000 
genes. Every person has two copies of each gene, one inherited from each parent. 
Most genes are the same in all people, but a small number of genes (less than one 
percent of the total) are slightly different between people. Alleles are forms of the 
same gene with small differences in their sequence of DNA bases. These small 
differences contribute to each person’s unique physical features15.  
According to Cavalli-Sforza & Bodmer, genetic polymorphism is the 
occurrence in the same population of two or more alleles at one locus, each with 
appreciable frequency, where the minimum frequency is typically taken as 1%.
15 
In 
other words, polymorphism is natural variations in a gene, DNA sequence, protein, or 
chromosome that have no adverse effect on the individual and occur with fairly high 
frequency in the general population. Association between polymorphism and genetic 
disease is widely accepted. Association between genetic polymorphism and dental 
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fluorosis were studied among following genes includes Collagen type I alpha 2 
(COL1A2 gene) PvuII, RsaI
11
, Osteocalcin (OC gene) Hind III
12
, Estrogen receptor 
(ESR gene) RsaI
13
, Parathyroid hormone (PTH gene) Bst BI
14
. Among all the genes, 
COL1A2 (PvuII) gene polymorphism was found to be significantly associated with 
vulnerability to dental fluorosis.
 
Type I collagen is the most abundant and ubiquitously distributed of the 
collagen family of proteins. It is a heterotrimer comprising two pro- α1(I) chains and 
one pro-α2(I) chain which are encoded by the unlinked loci COL1A1 and COL1A2 
respectively. COL1A1 is ~18 kb in size and is located at 17q21.3–q22. COL1A2 is   
~38 kb and is located at 7q21.3–q22.1. Specifically, the COL1A1 gene produces a 
component of type I collagen, called the pro-alpha (I) chain; whereas the COL1A2 
gene produces the pro-alpha2 (I) chain
16
.   
Till date, mutations in the COL1A2 gene in particular have been linked to a 
wide spectrum of diseases of bone, cartilage, and blood vessels. Because of their 
important role in bone formation and bone architecture, genetic polymorphisms in 
COL1A2 gene, which are related to bone pathogenesis, may influence the tooth 
formation of high-fluoride exposed subjects resulting in the vulnerability to dental 
fluorosis. Detection of such genes can help in identifying biomarkers for dental 
fluorosis. This information can be used in modifying   person’s susceptibility and 
there by alter an individual’s risk of getting dental fluorosis. 
The first evidence of an association between PvuII (CAG^CTG) (i.e., A 
sequence of DNA that is recognized by an endonuclease as a site at which the DNA is 
to be cut) polymorphism in the COL1A2 gene with dental fluorosis in high fluoride 
exposed populations was shown by Huang et al. 2008
11
. Although previous research 
Introduction 
 
 
 
 
6 
 
has reported COL1A2 allele frequencies in different populations (17-19), the 
differential effect on gene expression is unclear till now
11
. Scientific literature 
revealed very limited studies on genetic polymorphism (COL1A2) and dental 
fluorosis in India. Thus, the present study was conducted to assess the association 
between COL1A2 (PvuII) gene polymorphism and severity of dental fluorosis 
amongst patients attending the outpatient department of TNGDCH. 
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REVIEW OF LITERATURE 
The risk of developing dental fluorosis appears to be greatest when exposure 
occurs during both secretory and maturation stages of enamel formation
20
. There are 
multiple sources of fluoride and all have the potential to cause dental fluorosis 
including natural fluoride, artificial or added fluoride in drinking water and dental 
products, as well as occupation-related exposures
21
. The severity of fluorosis is related 
to the concentration of fluoride in the plasma, fluoride levels are influenced by many 
factors, including total fluoride intake, type of intake [i.e. ingested vs. inhaled], age of 
intake, renal function, rate of bone metabolism, metabolic activity
21
 etc.  
In addition to those major risk factors previously identified [use of fluoridated 
drinking water, fluoride supplements, fluoride toothpaste, and infant formulas] other 
factors, including critical periods of fluoride exposure during tooth development and 
individual variation, are important as well
22
. Also, genetic factors have been shown to 
dictate the severity of enamel fluorosis
22
. This may be the reason why in human 
populations, individuals ingesting water with similar fluoride contents have a wide 
range of severity of dental fluorosis. 
Very few studies have explored the genetic susceptibility to dental fluorosis. 
The following are the   reviewed previous studies which were carried out to assess the 
association between COL1A2 [PvuII] gene polymorphism and severity of dental 
fluorosis.  
Genetic Influence on Fluorosis: 
Everett et al [2002] found differences in susceptibility to development of 
dental fluorosis among 12 inbred mice strains that were studied. Three treatment 
groups were given fluoride in drinking water at levels of 0 ppm, 25 ppm and 50 ppm 
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72 mice in each treatment group with six mice of each genotype.  A/J mouse strain is 
highly susceptible, with a rapid onset and severe development of dental fluorosis and 
the 129P3/J strain to be the least affected strain compared with that in the other strains 
tested
22
. 
Zhang et al [2006] have shown that 10 microM sodium fluoride down-
regulates expression of matrix metalloproteinase-20 in human fetal tooth ameloblast-
lineage cells, but did not alter the amount of amelogenin or kalikrein-4 [KLK-4] 
synthesized by the cells
23
.  
Mousny et al [2006] investigated the genetic influence on bone susceptibility 
to fluoride. They studied three mice strains that demonstrate different susceptibilities 
to developing enamel fluorosis  includes A/J a ‘susceptible’ strain, 129P3/J a 
‘resistant’ strain and SWR/J an intermediate’ strain. These mice were divided into 
treatment groups based on fluoride exposure at concentrations of 0 ppm, 25 ppm, 50 
ppm, 100 ppm. They found that fluoride treatment did not have much influence on 
bone mineral density, but mechanical testing showed there were significant alterations 
in bone quality in the A/J strain, moderate alterations in the SWR/J strain and no 
effects in the 129P3/J strain. The results from their study suggest that genetic factors 
may contribute to the variation in bone response to fluoride intake and that fluoride 
might affect bone properties without altering bone mineral density.
24
 
Yue Baa et al [2009] conducted a case-control study among children aged 8–
12 years, to investigate the association between dental fluorosis, serum calciotropic 
hormone level, and polymorphisms in the OC gene HindIII. No significant 
relationship was found between OC HindIII polymorphisms and the dental fluorosis
25
. 
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Gang Wang et al [2010] conducted a case-control study among chinese 
children aged 8 to 12 years old [n=74] or without [n = 163] dental fluorosis to  
investigate the relationship between ER gene RsaI polymorphisms and  dental 
fluorosis by genotyped using the PCR-RFLP procedure. There were no significant 
differences in the three groups [P>0.05]
26
. 
Pamela et al [2011] in their review stated that genetic factors have been shown 
to dictate the severity of enamel fluorosis
21
. 
Everett et al [2011] in his review focussed the interaction of an individual’s 
genetic background has offered new insight into fluoride’s physiological effects27. 
Wen S et al [2012] conducted a case-control study among 225 children to 
explore the association of parathyroid hormone [PTH] gene Bst BI polymorphism, 
serum osteocalcin, calciotropic hormone levels, and dental fluorosis of children. No 
significant relationship was found between PTH Bst BI polymorphisms and the dental 
fluorosis
28
. 
Marília et al [2014] also found that A/J mice strain increased susceptibility to 
dental fluorosis
29
. 
COL1A2 gene polymorphism: 
Petros Tsipouras et al [1983] in their study showed the RFLP generated at the 
EcoRI in the 5'-region of the gene was used to study a family [18 individuals in four 
generations] with an autosomal dominant form of osteogenesis imperfecta. The data 
demonstrated a linkage of the phenotype to a proa2[I] allele with a lod score of 2.41
30
. 
Kuivaniemi et al [1991] in their study suggest that mutations in type I 
procollagen [COL1A1 and COL1A2] procollagen genes may cause a wide spectrum 
of both rare and common human diseases
31
. 
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Loretta et al [1992] their study results suggest that the isodisomy was not 
complete because of a recombination event involving the proximal short arms of two 
maternal chromosomes. In addition, the phenotype of proportional dwarfism in the 
proband suggests imprinting of one or more growth-related genes on chromosome 7
32
. 
Raymond Dalgleish [1997] stated that mutations at COL1A2 lociresult 
primarily in the connective tissue disorders osteogenesis imperfecta and Ehlers–
Danlos syndrome types VIIA and VIIB. Two instances  of osteoporosis and a single 
instance of Marfan syndrome
33
. 
Jarmo Korkko et al [1998] in their study they detected COL1A1 mutations in 
Patients with Osteogenesis Imperfecta Type I in 13 of the 15 patients by PCR 
Amplification and Scanning by Conformation-Sensitive Gel Electrophoresis identified 
common sequences of null-allele mutations
34
. 
Andre. G. Uitterlinden et al [1998] carried out a study to determine COLIA1 
genotypes SS, Ss, and ss in a population-based sample of 1778 postmenopausal 
women using a polymerase-chain reaction based assay and reported that women with 
the Ss and ss genotypes were overrepresented among the 111 women who had incident 
nonvertebral fractures [relative risk per copy of the s allele, 1.5; 95 percent confidence 
interval, 1.1 to 2.1]
35
. 
Paul A. Dawson et al [1999] in their case report they reported the 
identification of a novel mutation in the COL1A2 gene have an a2[I]Gly436 among 
two siblings who came to medical attention with juvenile osteoporosis
19
. 
Val Mann et al [2001] in his study showed that that the COL1A1 Sp1 binding 
site polymorphism has functional effects on collagen gene regulation that leads to 
abnormal production of the α1[I] collagen chain relative  to α2[I] and reduced bone 
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strength by mechanism that are partly independent of bone mass and predisposes to 
osteoporotic fractures
36
. 
Andre.G.Uitterlinden etal [2001] analyze the combined influence of 
polymorphisms in the Vitamin D receptor [VDR] gene and the COLIA1 gene in 
determining the susceptibility to osteoporotic fracture, among 1004 postmenopausal 
women. They observed significant interaction [p 5 0.03] between VDR and COLIA1 
genotype effects. COLIA1 “risk” group [genotypes GT and TT] the risk of fracture 
was 2.1 [95%CI, 1.0–4.4] for heterozygous and 4.4 [95%CI, 2.0 –9.4] for 
homozygous carriers of the VDR risk haplotype
37
. 
Suuriniemi M et al [2003] conducted a case control study to evaluate the 
associations between the polymorphic PvuII site of the COL1A2 gene and bone 
properties assessed by different modalities includes peripheral quantitative computed 
tomography, dual-energy X-ray absorptiometry, gel coupling scanning quantitative 
ultrasonometry, ultrasound bone sonometry, bone turnover markers, and the 
occurrence of fractures in 244 prepubertal Finnish girls. The P alleles were over-
represented in girls who had been fractured at least once; 88% of them had at least one 
copy of the P allele [either PP or Pp]. Girls with the PP genotype had 4.9 times higher 
relative risk for fractures than girls with the pp genotype [95% CI, 1.4 to 17.4; P = 
0.015]. No significant difference was found between fractured and nonfractured girls 
in anthropometric measurements, physical activity, or bone mass, Tanner stage and 
physical characteristics among girls with different COL1A2 genotypes.
17 
Shu-Feng Leia et al [2005] test the effect of collagen type I α 2[COL1A2] 
genes on the variation of bone size  and height by genotyping the MspI and [GT]n 
markers in the intron 47 and intron 1 of the COL1A2 gene in 400 Chinese nuclear 
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families with a total of 1256 individuals The association results indicate that the [GT]n 
and MspI markers of COL1A2 gene may have some influence on the variation of both 
bone size  and height
38
. 
Mikhail M Kostik et al [2013] conducted a study among 196 children with 
Juvenile idiopathic arthritis reported that polymorphism of COL1A1 has shown 
negative effect on BMD and mineral turnover related to pubertal stage
39
. 
 
Genetic Disorders of Mineralized Tissues of Teeth 
Stephanopoulos et al [2005] reported that there are seven candidate genes 
which play a role in etiology of Amelogenesis imperfecta and they are amelogenin, 
enamelin, ameloblastin, tuftelin, distal-less homeobox 3, enamelysin, and        
kallikrein 4
40
.  
Kim et al, [2006] analysed a gene mutation in 24 families with isolated enamel 
defects. Out of 24 families with isolated enamel defects, six disease causing mutations 
were identified in the Amelogenesis imperfecta candidate genes
41
.  
Hu et al [2007] in their study mentioned that genes expressed by odontoblasts 
[COL1A1, COL1A2, and DSPP], and ameloblasts [AMELX, ENAM, MMP20, and 
KLK4] during the crown formation stage, are associated with dentinogenesis 
imperfecta, dentin dysplasia, and amelogenesis imperfecta
42
. 
Kim et al [2007] shown that among types I, II and III dentinogenesis 
imperfect, type I dentinogenesis imperfecta is associated with osteogenesis imperfecta 
and defects in the two genes encoding type I collagen [COL1A1, 17q21.31–q22; 
COL1A2, 7q22.1] The remaining types of defects are associated with a defect in the 
DSPP gene, which is a noncollagenous protein-expressing gene
43
.  
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Huang et al.[2008] conducted a case-control study among  chinese children 
between 8 and 12 years of age with [n = 75] and without [n = 165] dental fluorosis to 
investigate the relationship between polymorphisms in the COL1A2[Pvu II and RsaI] 
gene and dental fluorosis they reported Children carrying the homozygous genotype 
PPof COL1A2 PvuII had a significantly increased risk of dental fluorosis [OR =4.85, 
95% CI: 1.22–19.32] Huang et al [2008], in one of the few published studies that 
examined the influence of specific candidate genes, investigated the relationship 
between dental fluorosis and polymorphisms in the COL1A2 gene among children in 
china. They conducted a case-control study among children between 8 and 12 years of 
age with [n = 75] and without [n = 165] dental fluorosis. They found that the children 
who were homozygous for PP genotype of COL1A2 PvuII had a significantly 
increased risk of dental fluorosis [OR =4.85, 95% CI: 1.22-19.32] when compared to 
children carrying the same genotype [pp] in an endemic fluorosis village. However, 
the risk was not elevated when the control population was recruited from a non-
endemic fluorosis village. Their findings provide evidence of an association between 
polymorphisms in the COL1A2 gene with dental fluorosis in high fluoride exposed 
populations, which is evidence for presence of interaction between fluoride intake and 
the genotype.
 44 
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AIM AND OBJECTIVES 
AIM 
The aim of the study is to assess the association between COL1A2 (PvuII) 
gene polymorphism and severity of dental fluorosis amongst patients attending the  
outpatient department of TNGDCH. 
OBJECTIVES: 
1. To assess the details of fluoride exposure among participants using a 
prevalidated customized case record form   with questionnaire. 
2. To assess the severity of dental fluorosis using the Dean’s fluorosis index 
(1942). 
3. To assess the PvuII polymorphisms in the COL1A2 gene by genotyping  using 
the PCR-RFLP procedure. 
4. To prove the association between polymorphism in the COL1A2 PvuII  gene 
with severity of  dental fluorosis 
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MATERIALS AND METHODS 
 
STUDY DESIGN                                 : Cross sectional study 
DURATION OF STUDY                    : 5 months  
                  Started on: July 2014  
                                                                  Ended on:  November 2014 
SAMPLING METHODOLOGY:  
Samples were selected based on the following selection criteria from the 
outpatient department of Tamil Nadu Government Dental College and Hospital, 
Chennai-3 by simple random sampling method.  
Inclusion criteria: 
1. Individual affected by dental fluorosis above 6 years of age.  
Exclusion criteria: 
1. Cases presenting with known syndromes. 
2. Cases with known bleeding and clotting disorders 
3. Cases with known bone disorders. 
4. Cases receiving drug treatment in the form of bisphosphonates, calcitonin, and    
fluoride    
5. Patient suffering from acute painful conditions. 
SAMPLE SIZE DETERMINATION: 
Sample size was calculated with power of study as 90% and alpha error at 5% 
using n-master software as 120 participants [15 participants were recruited in each 
category of 1-4 grades and 30 participants in each category of 0 and 0.5 grades of 
Dean’s fluorosis index (1942)]. Hence making the sample size of 120.  
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Sample size calculation formula 
                                      n =      ( Z (1-α)/2 )
 2
   p (1-p)  
                                                                d
2 
Z (1-α)/2   - is standard normal variate at 5% type I error (i.e., 1.96) 
p- expected proportion of patients with dental fluorosis  based on census report of     
   TNGDCH.  
d- absolute error or precision 
                                       n =        (1.96)
2
   0 .04 (1-0.04)   =   58.9 
                                                                (0.05)
2 
 
ARMAMENTARIUM USED: 
  a. Pre validated customized case record form with questionnaire  
  b. Mouth mirror 
  c. Explorer (No.23)  
  d. Equipments and materials  
Equipments and materials: 
i. For blood collection: 
1. Sterile gloves and cotton rolls  
2. 2ml K3 EDTA vacutainer (Translucent lavender Hemogard safety closure, 
     Medical Grade PET tube, 13mm x 75mm, K3 EDTA (spray) 5.4mg, Block 
     Label) stored in sample collection box 
3. Thermocol ice box  
4. Gel pack  
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ii. DNA extraction:           
1. DNA extraction kit (company name: FavorPrep) containing: 
a. RBC lysis buffer 
b. GB buffer 
c. W1 buffer 
d. Wash buffer 
e. Elution buffer 
f. GT buffer 
g. GB column and tubes  
2. 95-100% Ethyl alcohol 
3. Microcentrifuge tubes 
4. PCR tubes  
5. Micropipette (10-1000µl, 20-200µl) 
6. Micropipette tips (1000µl, 200µl, 20µl) 
7. Centrifuge machine  
8. Nano- Drop 2000cc UV-Vis Spectrophotometer 
9. Deep freezer (-200 c ,-800 c)            
iii. Polymerase Chain Reaction: 
1. Primer (company name: Shrimpex)  
2. Master mix (company name: Thermo scientific Pfu DNA polymerase#EP0571  
3. Polymerase Chain Reaction (PCR) Machine (BIO-RAD thermal cycler) 
4.  Tris-borate-EDTA (TBE) 10 X buffer  
5. Bromophenol blue (Tracking dye) 
6. Ethidium Bromide (DNA intercalator)  
Materials and Methods 
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7. 1% Agarose gel 
8. Electrophoresis machine  
9. DNA ladder (1kb) (GeneRuler, Thermo scientific) 
10.Restriction enzyme (PvuII enzyme) [Company name: New England Biolab (NEB)] 
iv. Gel/PCR purification kit 
a. FADF buffer  
b. Wash buffer 
c. Elution buffer  
d. 2 ml collection tube  
v. Pvu II restriction enzyme (10U/µl) #ER0635 
a. PvuII is supplied in: 10 mM Tris-HCl (pH 7.4 at 25°C), 100 mM KCl,  
     1 mM DTT, 1 mM EDTA, 0.2 mg/ml BSA, and 50% (v/v) glycerol. 
b. 1 X  buffer G 
(The PvuII restriction enzyme recognizes CAG^CTG sites and cuts best at 37°C in  
      1X buffer G) 
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METHODOLOGY: 
1. Ethical clearance:  
Ethical clearance was obtained from the Institutional Review Board of Tamil 
Nadu Government Dental College and Hospital, Chennai. 
2. Sampling procedure: 
Samples were recruited by simple random sampling method from outpatient 
department   of Tamil Nadu Government Dental College and Hospital, Chennai.  
Based on Dean’s fluorosis index (1942) participants (Photograph 1 to 6) were 
categorized as follows: 
1. Normal (30 participants) 
2. Questionable (30 participants) 
3. Very mild (15 participants) 
4. Mild (15 participants) 
5. Moderate and (15 participants) 
6. Severe dental fluorosis (15 participants) 
3. Informed consent:  
Informed consent (bilingual) was obtained from the selected participants of the 
study after the patient has duly read the information sheet. (Annexure I and II) 
4. Administration of questionnaire: 
A prevalidated customized case record form with questionnaire was 
administered to participants, and details of their fluoride exposure and severity of 
dental fluorosis were recorded. (Annexure III)  
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5. Blood collection and storage: 
One to two ml of blood was collected from participants, through venipuncture 
of the median cubital vein or cephalic vein or basilic vein as indicated, in a 2ml 
disposable syringe and transferred into 3ml K3 EDTA vacutainer tube by a trained 
staff nurse at TNGDCH. The blood collected was transferred to a sample collection 
box containing gel packs and was transported to Madras Veterinary College, Dept of 
Microbiology, and stored at 4
0
C cold room. [Photograph 23] 
6. DNA extraction: 
DNA was retrieved from the blood sample using the buffer solutions available 
in the DNA extraction kit (FavorPrep Genomic DNA extraction mini kit), by the 
below mentioned steps as per manufacturer’s guidelines. [Photograph 7, 8]                                                      
Step 1: RBC lysis 
300µL of fresh blood was transferred from the K3 EDTA tube into a 1.5ml micro-
centrifuge tube. . [Photograph 9, 10] 
a. To this 3 volumes of RBC lysis buffer (900µL) was added and mixed by inversion. 
b. The sample was incubated at room temperature for 10 minutes [Photograph 11,12] 
c. The sample was then centrifuged at 3000 rpm for 5 minutes and the supernatant 
obtained was discarded. [Photograph 13,14 ] 
d. 100µL of RBC lysis buffer was added to resuspend the cell pellet[Photograph 15,16  
Step 2: Cell lysis 
a. 200µL of GB buffer was added to the 1.5ml micro-centrifuge tube and mixed by 
vortexing. [Photograph 17,18 ] 
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b. The mixture was then incubated at room temperature for 10 minutes until the 
sample lysate cleared. During incubation, the micro-centrifuge tube was inverted 
every 3 minutes. 
c. The required elution buffer (200µL) for the final step of DNA extraction, was taken 
in a PCR tube and placed in a 70
o
C water bath.  
Step 3: DNA binding 
a. After incubating the sample for 10 minutes, 200µL of ethanol (96-100%) was 
added to the sample lysate and mixed immediately by vortexing. Any precipitate 
which appeared was broken up by pipetting.  
b. A GB column was then placed in the 2ml collection tube. The entire mixture was 
then transferred into the GB column. [Photograph 19 ] 
c. The GB column was then centrifuged at full speed 13,000 rpm for 5 minutes, after 
which the collecting tube containing the flow – through was discarded and the GB 
column was transferred into a new collection tube. 
Step 4: Wash 
a. 400µL of W1 buffer was then added into the GB column and then centrifuged at 
full speed of 13,000 rpm for 30 seconds, after which the flow-through alone was 
discarded and the GB column was placed back in the same 2 ml collection tube.  
b. 600µL of wash buffer (ethanol added) was added into the GB column and then 
centrifuged at full speed of 13,000 rpm for 30 seconds, after which the flow-
through alone was discarded and the GB column was placed back in the 2 ml 
collection tube. 
c. The GB column was then centrifuged at full speed at 13,000 rpm for 3 minutes to 
dry the column matrix 
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Step 5: DNA Elution 
a. The GB Column was then transferred into a clean 1.5 ml micro-centirfuge tube  
b. To this 100µL of preheated elution buffer was added into the center of the column 
matrix and allowed to stand at room temperature for 3-5 minutes until the elution 
buffer was absorbed by the matrix. 
c. The sample was then centrifuged at full speed 13,000 rpm for 30 seconds to elute 
the purified DNA [Photograph 20 ] 
After obtaining purified DNA, the sample was transferred into a PCR tube 
(sample number marked) and the quantity of DNA obtained in the sample was 
recorded using a spectrophotometer (NanoDrop 2000c) which depicted the 
concentration of DNA in ng/µl and the purity of the DNA sample in A260/A280 ratio.  
[Photograph 21, 22] 
The sample in the PCR tube was stored in a deep freezer (temperature at            
- 80
o
C) until sufficient samples were obtained to start with PCR analysis. 
[Photograph 24] 
7. Polymerase Chain Reaction: 
A Polymerase Chain Reaction (PCR) procedure that produces millions of 
copies of a short segment of DNA through repeated cycles of: 1) denaturation,            
2) annealing, and 3) elongation. PCR is a very common procedure in molecular 
genetic testing and may be used to generate a sufficient quantity of DNA to perform a 
test (e.g., sequence analysis, mutation scanning, restriction fragment length 
polymorphism analysis
45   
[Photograph 25,26 ]
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Restriction fragment length polymorphism analysis: 
Fragment of DNA of predictable size resulting from digestion (cutting) of a 
strand of DNA by a given restriction enzyme. DNA sequence alterations (mutations) 
that destroy or create the sites at which a restriction enzyme cuts DNA change the size 
(and number) of DNA fragments resulting from digestion by a given restriction 
enzyme
45
. 
A Polymerase Chain Reaction (PCR) method coupled to restriction fragment 
length polymorphism analysis was used to identify the COL1A2 gene polymorphism. 
Primers used in the present study were obtained in accordance to Suuriniemi M 
et al 2003
17
, they include: 
COL1A2 F (5’-GGG ATA TAA GGA TAC ACT AGA GG-3’) [FORWARD     
PRIMER] 
COL1A2 R (5’-GAA ATA TCG CCG CTG GAA-3’) [REVERSE PRIMER] 
These primers were prepared and used to amplify the fragment region of 
COL1A2 PVUII site suspected to exhibit polymorphism. [Photograph 27, 28] 
The Polymerase Chain Reaction (PCR) was performed in the total volume of 20µl 
reaction mixture for samples which was constituted as follows: 
     Master mix           : 10µl 
     Forward primer                                     :  2µl 
     Reverse primer                                      :  2µ 
     DNA template           :  2 µl  
     Nuclease free water         : 4 µl 
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The programme of PCR amplification (mentioned below) was set in the PCR machine 
(Bio-Rad). [Photograph 25, 26, 29]  
Step Temperature Cycles 
Initial Denaturation 94
0
C – 3 minutes   
Denaturation 94
0
C – 30 seconds  
Repeated for 30 cycles Annealing  56
0
C – 30 seconds 
Extension 72
0
C –  45 seconds 
Final Extension  72
0
C – 5 minutes   
 
Programme of PCR amplification 
 
                       94
0
C     94
0
C                               72
0
C           72
0
C   
                       3:00      0:30             56
0
C            0:45            5:00           4
0
C 
                                                        0:30 
                                                          30 cycles 
8. Detection of PCR products: 
The PCR products were detected by electrophoresis in a 1% agarose gel in 
TBE (10X) buffer. Agarose was dissolved in TBE buffer by heating and cooled to 
50
0
C. To this Ethidium Bromide (Dye, DNA intercalator) was added to a final 
concentration of 0.5µg per ml. [Photograph 29] 
The clean, dry, gel platform edges were sealed with adhesive tapes and the 
comb was kept in proper position before pouring the agarose. Once the Agarose gel 
was set the comb and the adhesive tape were removed gently and the gel tray was 
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placed in the buffer tank. Then the TBE buffer was poured till the top of the gel drown 
in the buffer. [Photograph30, 31] 
The PCR product (5µl) was loaded into the respective wells along with the 
molecular marker (1Kb DNA ladder). The electrophoresis was carried out for 15 to 20 
minutes at 150 volts till the tracking dye (Bromophenol blue, placed in the first well) 
migrated more than two third the length of the gel tray in the buffer tank.  
The gel was then placed under UV transilluminator in gel documentation 
system (gel doc) to visualize the bands at 771 bp. [Photograph32, 33] 
9. Gel purification:  
Following PCR amplification, the products were subjected to gel purification. 
[Photograph 34] 
Steps for gel purification are as follows: 
1.  The agarose gel was excised with a clean scalpel. 
2. 300 mg of the gel slice was sliced under UV Trans illuminator   into a micro 
centrifuge tube. [Photograph 35] 
3.  500 µl of FADF buffer was added to the sample and mix by vortexing.  
4. The sample mixture was placed at 55 °C dry bath [Photograph 36] for 10-15 
minutes and vortex the tube every 2-3 minutes until the gel slice dissolved 
completely. 
5.  The sample mixture was cooled down to room temperature and place a FADF    
     column in a collection tube.  
6.  800 µl of the sample mixture was transferred to FADF column. The sample was    
     then centrifuged for 30 seconds and the supernatant obtained was discarded. 
7.  750 µl of wash buffer (ethanol added) was added to the FADF column and   
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      centrifuged for 30 seconds then flow-through was discarded and centrifuged     
      again for an additional 3 minutes to dry the column.  
8.  The FADF column was placed to a new microcentrifuge tube. 
9.  40 µl of elution buffer was added to the membrane center of the FADF column.  
10. To elute the DNA centrifuged it for 2 minutes. 
11. The DNA obtained was stored at -20 °C. 
10. Restriction fragment length polymorphism analysis: 
The purified products thus obtained were subjected to digestion by the 
restriction enzyme (PvuII) and incubate at 37
0
C up to 16 hours. [Photograph 37,38,39] 
Restriction enzyme (or restriction endonuclease) is an enzyme that cuts DNA 
at or near specific recognition nucleotide sequences known as restriction sites
45
. 
A total of 20µl of reaction mixture was used for samples as follows: 
Nuclease free water                      : 14µl 
Buffer   G                            :  2µl 
            PCR product         :  3µl 
PVU II enzyme        :  1µl 
The resulting fragments obtained were subjected to electrophoresis in            
1% agarose gel in a similar procedure mentioned earlier. 
11. Recording the PvuII restriction enzyme digestion: 
Gene frequency: The proportion of individuals in a population who have inherited a 
specific gene mutation or variant
45
.  
The gel was placed in gel documentation system (gel doc) and the observable 
bands were visualized and recorded. The PCR products containing p alleles were 
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cleaved by PvuII, resulting in bands of 541 bp and 239 bp compared with the 
uncleaved P alleles band of 771 bp. 
After the post electrophoresis gel treatment the purified DNA fragments of 
three samples of different genotype frequencies underwent direct sequencing to 
confirm the RFLP results. 
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STATISTICAL ANALYSIS 
 Data obtained was analyzed using Statistical package for Social Sciences (SPSS) 
software version 17. 
  The association between polymorphism in the COL1A2 gene with severity of 
dental fluorosis was assessed by chi-square test. 
 Hardy-Weinberg equilibrium was checked using control-only chi square (χ²) test 
 ANOVA test was performed to compare between fluoride levels in water and 
COL1A2 polymorphism. Tukey’s HSD test to compare within the three COL1A2 
genotype frequencies and fluoride level  
 Spearman’s rank correlation  was employed to find correlation between groups 
based on severity of dental fluorosis and type of COL1A2 genotype 
 Unadjusted odds ratio was calculated using multivariate logistic regression 
analysis. 
 In the present study, the level of significance (α) was fixed at 5%. (p≤ 0.05) 
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Cases 
Age in 
years Sex 
Paternal  
history 
Maternal  
history 
Fluoride  
level in 
water(ppm) 
Severity of Dental 
fluorosis 
COL1A2 
genotype  
1 23 Male No Yes 7.5 Moderate pp 
2 30 Male Yes No 7.5 Moderate Pp 
3 21 Male No No 3 Moderate Pp 
4 21 Male Yes No 3 questionable pp 
5 25 Male Yes No 3 questionable pp 
6 16 Female No No 3 Very mild Pp 
7 21 Female No No 2.8 Mild PP 
8 20 Female No Yes 2.8 Severe pp 
9 18 Male No No 2.8 Moderate Pp 
10 22 Female No No 2.8 Moderate Pp 
11 24 Male No No 3 Severe Pp 
12 21 Male No No 3 Very mild Pp 
13 24 Female No No 3 questionable pp 
14 18 Male No No 1.5 Moderate pp 
15 44 Male No No 3 Mild pp 
16 23 Male No No 4 Severe pp 
17 24 Male No Yes 3.2 Moderate PP 
18 26 Male No Yes 1.4 questionable pp 
19 18 Male No No 1.2 questionable pp 
20 24 Male No No 7.5 Very mild pp 
21 21 Female No No 3 Very mild PP 
22 21 Male No No 3 Mild PP 
23 21 Female No No 2 Very mild pp 
24 21 Female No No 3.2 Very mild pp 
25 21 Male No No 3 Moderate PP 
26 32 Male Yes No 3 Severe PP 
27 21 Female No No 1.8 Very mild pp 
28 26 Male No No 3 Severe PP 
29 20 Female No No 3 Severe Pp 
30 21 Female No No 4 Mild Pp 
31 22 Male No Yes 1.4 questionable pp 
32 23 Male No No 1.4 Mild PP 
33 24 Male No No 1.5 Very mild Pp 
34 21 Female No No 1.4 questionable pp 
35 23 Male No Yes 7.6 Moderate Pp 
36 17 Female No No 1.5 Severe pp 
37 19 Male No No 1.5 Moderate PP 
38 25 Male No No 7.5 Mild Pp 
39 21 Male No Yes 1.8 Moderate pp 
40 18 Male Yes No 2.8 Severe PP 
41 35 Male No No 3 Severe pp 
42 24 Female Yes No 3.6 Very mild pp 
43 13 Female No No 2 Moderate PP 
44 11 Female No No 2 Moderate PP 
45 21 Male No Yes 2.2 Severe Pp 
46 20 Male No No 7.6 Moderate Pp 
47 26 Female No No 7.5 Very mild PP 
48 24 Male Yes No 3 Severe pp 
49 23 Female No No 3 Severe Pp 
50 24 Male No No 2.8 questionable pp 
51 26 Male Yes Yes 7.5 Mild pp 
52 18 Male No Yes 2.8 Severe PP 
53 30 Male No No 3.2 questionable pp 
54 21 Male No No 7.5 Severe pp 
55 25 Male Yes No 2.2 Very mild Pp 
56 23 Male No No 3.2 Severe Pp 
57 39 Male No No 7.5 Mild pp 
58 20 Male No No 2.8 Mild PP 
59 19 Male No No 1.4 normal pp 
60 22 Female Yes No 3.2 questionable pp 
61 18 Male No Yes 7.6 Mild pp 
Table.1. Master table showing Family history, Fluoride exposure level in water, severity of 
 dental fluorosis and COL1A2 genotype of the participants 
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62 32 Male No No 2.8 Mild pp 
63 36 Male No No 2.4 questionable pp 
64 19 Male No No 1.5 Mild Pp 
65 21 Male No No 3 Mild Pp 
66 24 Male No No 7.5 Moderate PP 
67 23 Male Yes Yes 7.5 Mild PP 
68 30 Male Yes Yes 7.6 questionable pp 
69 23 Male No No 3 questionable pp 
70 21 Male Yes No 1.5 Very mild PP 
71 22 Male Yes No 2.8 questionable pp 
72 36 Female No Yes 3 questionable pp 
73 33 Female No No 7.6 normal pp 
74 28 Female No No 1.4 normal PP 
75 32 Female No No 3 normal pp 
76 22 Female Yes No 3 Mild Pp 
77 24 Female No No 1.4 normal pp 
78 25 Female No No 3 Very mild PP 
79 37 Female No No 1.4 normal pp 
80 40 Male No No 1.4 normal pp 
81 34  Male No No 1.4 normal pp 
82 31 Female No No 1.4 normal pp 
83 36 Female No No 2 Very mild Pp 
84 38 Male No No 1.4 normal pp 
85 56 Female No No 2.8 questionable Pp 
86 26 Male No Yes 1.5 Very mild Pp 
87 36 Female No No 1.4 normal pp 
88 21 Female No No 1.4 normal pp 
89 21 Male No No 3.6 normal pp 
90 21 Female No No 1.4 normal pp 
91 21 Female No No 1.4 normal pp 
92 34 Male No No 1.4 questionable Pp 
93 33 Male No Yes 3 questionable pp 
94 33 Male No No 1.4 questionable pp 
95 43 Male No No 2.4 questionable pp 
96 23 Female No Yes 3.6 questionable pp 
97 38 Male No No 3.2 normal pp 
98 28 Male No No 3 normal Pp 
99 23 Male No No 1.4 normal Pp 
100 19 Male No No 3 normal Pp 
101 32 Male No No 1.4 normal Pp 
102 34 Female No No 1.4 normal Pp 
103 23 Male Yes No 3.2 questionable Pp 
104 25 Male No No 2 normal Pp 
105 26 Male No No 2.8 questionable pp 
106 24 Female No No 7.5 questionable pp 
107 27 Male No No 2 questionable pp 
108 29 Male No Yes 7.6 questionable pp 
109 28 Female No No 2.4 normal pp 
110 22 Female No No 5.6 questionable pp 
111 24 Male No No 3 questionable pp 
112 31 Female No No 3 questionable pp 
113 19 Male No No 3.2 normal pp 
114 18 Female No No 5.6 normal pp 
115 26 Female No Yes 3.2 questionable pp 
116 24 Male No No 3 normal pp 
117 22 Female No No 3 normal pp 
118 21 Male No No 2.8 normal pp 
119 23 Male No No 2.8 normal pp 
120 30 Male No No 3.2 normal pp 
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                                                 PHOTOGRAPH 1 
INTRA ORAL PHOTOGRAPHS OF STUDY PARTICIPANTS -  
BASED ON DEAN’S FLUOROSIS INDEX (1942) 
 
          1.1. Normal [0]                                                         1.2. Questionable [0.5] 
        
            1.3. Very mild [1]                                                          1.4. Mild [2] 
        
             1.4. Moderate [3]                                                        1.5. Severe [4] 
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DNA ISOLATION PROCEDURE  
 
                PHOTOGRAPH 2                                                 PHOTOGRAPH 3 
                 DNA Isolation kit                                         Armamentarium for DNA Isolation  
                         
 
 
 
 
PHOTOGRAPH 4.1                                                   PHOTOGRAPH 4.2 
Step 1 - RBC lysis procedure 
300 l of blood sample in micro-centrifuge tube 
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                 PHOTOGRAPH 4.3                                                PHOTOGRAPH 4.4 
900 l of RBC lysis buffer added to blood sample 
 
                          
 
 
 
 
 
 
                 PHOTOGRAPH 5.1                                                PHOTOGRAPH 5.2 
Centrifuge machine used  
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                 PHOTOGRAPH 6.1                                                PHOTOGRAPH 6.2 
Pellet obtained after RBC lysis 
                         
 
 
 
 
 
 
 
                 PHOTOGRAPH 7.1                                                PHOTOGRAPH 7.2 
STEP 2- Procedure of cell lysis 
           Vortex machine                                                                        Incubation 
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                 PHOTOGRAPH 8                                               PHOTOGRAPH  9 
         Step 3- DNA binding procedure                            Step 4- DNA elution procedure 
                     
 
 
 
                 PHOTOGRAPH 10                                                   PHOTOGRAPH 11 
Nanodrop 2000 UV-Vis Spectrophotometer                Recording of concentration of DNA 
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            PHOTOGRAPH 12 
       Cold room 
                          
 
 
 
 
PHOTOGRAPH 13 
Deep freezer 
                     
 
 
 
Cold room used for storage of blood samples 
Deep freezer used for storage of DNA samples and enzymes 
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POLYMERASE CHAIN REACTION 
PHOTOGRAPH 14 
Thermal cycler (Bio Rad) 
 
 
 
 
PHOTOGRAPH 15  
PCR tubes loaded into the PCR machine 
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PHOTOGRAPH 16 
Armamentarium for PCR 
 
 
 
 
PHOTOGRAPH 17 
PCR programme  
 
PCR programme as set in the PCR machine 
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           PHOTOGRAPH 18                                                       PHOTOGRAPH 19 
                  Agarose gel tank                                       Samples loaded into the wells for electrophoresis 
                       
 
 
PHOTOGRAPH 20 
Armamentarium for gel electrophoresis 
 
 
 
              PHOTOGRAPH 21.1                                                  PHOTOGRAPH 21.2 
                                    Gel documentation system 
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GEL / PCR PURIFICATION PROCEDURE 
Armamentarium for gel purification 
 
 
                    PHOTOGRAPH 22                                             PHOTOGRAPH 23 
       Gel / PCR purification kit                                      UV Trans illuminator  
                     
 
 
 
 
PHOTOGRAPH 24 
          Dry bath 
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PVU II DIGESTION PROCEDURE 
 
PHOTOGRAPH 25.1                                                     PHOTOGRAPH 25.2 
PVU II enzyme and buffer in -20
0 
c cooler
 
 
                            
 
 
 
PHOTOGRAPH 26 
Incubator  
 
 
 
 
Samples with Restriction enzyme (PvuII) 
incubated at 37
0
C up to 16 hours. 
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ASSESSMENT OF QUESTIONNAIRE: 
I) DEMOGRAPHIC FEATURES  
1. Age: 
The mean age of the study participants were 25.2 ± 6.8 years. 
2. Gender: 
The study population comprised of 63.3% of males and 35.8% of females. 
(Figure 1) 
3. Religion: 
Hindus constituted 93.3% of the participants followed by 4.2% of the 
Christians and 2.5% of the muslims. (Figure 2) 
4. Socioeconomic status: 
Based on Modified Kuppuswamy’s socio-economic status scale (updated 
income parameter 2014), 38.3% of the participants belonged to the upper middle class, 
followed by lower middle class (33.3%). (Figure 3). 
5. Distribution of participants based on place of residence 
Figure 4 shows the district wise distribution of study population based on place 
of residence (0-8 yrs) and their severity of dental fluorosis as graded by Dean’s 
fluorosis index (1942). Among the cases of dental fluorosis, 18 of them were from 
Vellore district, 9 from Dharmapuri, 5 from erode, 4 from Namakkal whereas in 
normal and questionable group, 15 from Vellore district, 10 from Chennai corporation, 
each 5 from Erode and Namakkal districts. (Figure 4). 
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6. Distribution of genotypes based on severity of dental fluorosis 
According to Dean’s fluorosis index (1942), dental fluorosis was categorized 
as 0 (normal), 0.5 (questionable), 1 (very mild), 2 (mild), 3 (moderate), and 4 (severe). 
Among normal and questionable only 1.9% had PP genotype whereas in other groups 
(very mild, mild, moderate, and severe) there were 28.4%   participants had PP 
genotype was noticed. (Figure.5)  
Hardy-Weinberg equilibrium using control-only chi square (χ²) test 
The Hardy-Weinberg equilibrium model has five basic assumptions: 1) the 
population is large (i.e., there is no genetic drift); 2) there is no gene flow between 
populations, from migration or transfer of gametes; 3) mutations are negligible;           
4) individuals are mating randomly; and 5) natural selection is not operating on the 
population. Given these assumptions, a population's genotype and allele frequencies 
will remain unchanged over successive generations, and the population is said to be in 
Hardy-Weinberg equilibrium. The Hardy-Weinberg model can also be applied to the 
genotype frequency of a single gene. 
Testing for the Hardy-Weinberg equilibrium (HWE) is often used as an initial 
step for checking the quality of genotyping. It was calculated whether the genotypes in 
the control groups concurred with the Hardy Weinberg equilibrium (HWE) by use of a 
chi square test with one degree of freedom. HWE is an indicator of the representability 
of the study population compared with the general population. Deviations from HWE 
can indicate genotyping errors or a selection bias of the control group, thus hindering 
the interpretation of associations between diseases and genotypes. 
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Genotype 
Observed 
frequency 
Expected 
frequency 
Chi square 
value  
p-value 
pp genotypes 43            42.57  
0.4415 
 
0.506 Pp genotypes 9 9.86 
PP genotypes 1 0.57 
    The result is not significant at p < 0.05. 
              The observed and expected counts were not significantly different from one 
another   (p =0.506). This shows that allele and genotype frequencies at the COL1A2 
PvuII (in exon 25) in control participants were in Hardy-Weinberg equilibrium. 
(Table.2) 
Based on Dean’s fluorosis index (1942), participants who were diagnosed as 
grade 0 or 0.5 were considered as controls, whereas those who were diagnosed as 
grade 1, 2, 3, and 4, dental fluorosis were classified as cases of dental fluorosis. 
Among normal and questionable group, only 1.9% had PP genotype, 16.9 % had Pp 
genotype, and majority of them 81.2% had pp genotype whereas in cases of dental 
fluorosis 28.4%   of them had PP genotype. The genetic polymorphism in COL1A2 
PvuII was found to be associated with the risk of dental fluorosis. Compared to 
participants who carried homozygous p allele of COL1A2 PvuII, participants who 
carried homozygous P allele had a significantly increased risk of dental fluorosis with 
significant p value (p = .000) as shown in the Table.3 
 
 
 
 
TABLE.2. HARDY-WEINBERG EQUILIBRIUM FOR COL1A2 
GENOTYPES USING CONTROL-ONLY CHI SQUARE TEST  
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COL1A2 Pvu II 
polymorphism 
Severity of dental fluorosis Chi 
square 
value 
p value 
Normal and 
Questionable 
Very mild, Mild, 
Moderate, Severe  
PP genotype 1.9% 28.4%  
24.541 
 
0.000* Pp genotype 16.9 % 32.8% 
pp genotype      81.2% 38.8% 
      * - significant p value 
 
A sub group in cases of dental fluorosis was compared with normal and 
questionable. Participants with homozygous genotype PP were found to be associated 
with dental fluorosis compared to participants with the homozygous variant genotype 
pp. The association within grades of severity of dental fluorosis and COL1A2 
polymorphisms were found to be significant (p < 0.00125
a
), but the risk did not 
increase with severity of dental fluorosis. (Table.4) 
 
 
 
 
COL1A2 Pvu II 
polymorphism 
Severity of dental fluorosis 
Very mild 
and control 
Mild and 
control 
Moderate 
and control 
Severe and 
control 
PP genotype 23.6% 31.2% 37.5% 22.2% 
Pp genotype 35.2% 31.2% 37.5% 27.8% 
pp genotype 41.2% 37.5% 25% 50% 
Chi square value 13.332 16.714 23.430 10.463 
p value 0.001
*
 0.000
*
 0.000
*
 0.005
*
 
           * - significant p value 
 
 
 
 
TABLE.3. ASSOCIATION BETWEEN COL1A2 GENE POLYMORPHISMS  
AND DENTAL FLUOROSIS 
 
 
TABLE.4. ASSOCIATION BETWEEN COL1A2 GENE 
POLYMORPHISM AND THE GRADES OF SEVERITY OF DENTAL 
FLUOROSIS 
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Genotypes of COL1A2 polymorphism were correlated with severity grades of 
dental fluorosis (Dean’s fluorosis Index 1942). It had weak correlation (r = 0.398) with 
significant p value. (Table.4a) 
 
 
 
 
 
COL1A2 PvuII 
polymorphism 
Severity of dental fluorosis 
Correlation Coefficient p-value 
0.398
**
 0.001 
**. Correlation is significant at the 0.01 level  
 
Association between family history of dental fluorosis and COL1A2 
polymorphisms were found to be statistically insignificant (p > 0.05) as shown in 
table.5. 
 
 
S.no Family history of 
dental fluorosis 
COL1A2 Pvu II 
polymorphism 
Chi 
square 
value 
p 
value 
PP Pp pp 
1. Maternal history 3 3 13 0.413 0.814 
2. Paternal history 4 3 9 0.923 0.630 
 
           In the study population 90% of them used bore well water for drinking and 
cooking purpose in their first decade of the life. Hence the data of fluoride level of 
water in power pump forces from districts of Tamilnadu reported by Tamil Nadu 
Water Supply and Drainage Board (TWAD board) was used to compare the level of 
TABLE5. ASSOCIATION BETWEEN COL1A2 GENE POLYMORPHISMS  
AND FAMILY HISTORY OF DENTAL FLUOROSIS 
TABLE.4a. CORRELATION BETWEEN COL1A2 GENE 
POLYMORPHISMS AND SEVERITY OF DENTAL 
FLUOROSIS (SPEARMAN’S RANK CORRELATION) 
Results 
  
 
 
 
47 
 
fluoride exposure and COL1A2 genetic polymorphisms using ANOVA test. It was 
found to be statistically insignificant (p = 0.949). (Table.6.)        
Post hoc comparison within the genotype groups and fluoride exposure level 
was done with Tukey’s Honestly Significant Difference (HSD) test. It was found to be 
statistically insignificant in all comparisons (p > .05). (Table.6a) 
 
 
COL1A2 PvuII 
Polymorphisms 
Mean fluoride 
level in water 
(ppm) 
Standard 
deviation 
F  value p value 
PP  genotype 3.43 1.94 
0.052 0.949 Pp   genotype 3.48 1.94 
pp   genotype 3.59 1.95 
 
 
 
 
COL1A2  Pvu II 
Polymorphisms 
p value 
PP genotype 
Pp genotype 0.996 
pp genotype 0.955 
Pp genotype 
PP genotype 0.996 
pp genotype 0.974 
pp genotype 
PP genotype 0.955 
Pp genotype 0.974 
 
TABLE.6a. TUKEY’S HONESTLY SIGNIFICANT 
DIFFERENCE (HSD) TEST TO COMPARE AND LEVEL OF 
FLUORIDE EXPOSURE AND COL1A2 POLYMORPHISMS 
(POST HOC COMPARISON) 
TABLE.6. ASSOCIATION BETWEEN COL1A2 GENE POLYMORPHISMS AND 
LEVEL OF FLUORIDE EXPOSURE  
Results 
  
 
 
 
48 
 
The unadjusted odds ratio showed that the risk of dental fluorosis was 31.4 
times higher for the PP genotype group in relation to the pp genotype group and 4.0 
times higher for the Pp genotype group. Odds ratios (ORs) and 95% confidence 
intervals (CI) were calculated using non adjusted multivariate logistic regression 
analysis. (The exponential function of the regression coefficient (eb1) is the odds ratio) 
(Table.7.)  
    
 
COL1A2 Pvu II 
polymorphism 
Severity of dental fluorosis unadjusted 
odds ratio 
(e
b1
) 
95% 
Confidence 
Interval 
p value 
Normal and 
Questionable 
Very mild, 
Mild, 
Moderate, 
Severe 
pp genotype 81.2% 38.8% 1.0   
PP genotype 1.9% 28.4% 31.4 3.9 - 48.7 0.000 
Pp genotype 16.9 % 32.8% 4.0 1.6 - 10.1 0.003 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE.7. DENTAL FLUOROSIS RISK ACCORDING TO   COL1A2 GENOTYPE 
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FIGURE 1 
 
 
 
 
FIGURE 2 
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FIGURE 3 
  
 
     
 
   FIGURE 4 
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FIGURE 5 
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PHOTOGRAPH 27.1 
Electrophoresis result showing the COL1A2 PCR products  
 
 
  PHOTOGRAPH 27.1 
          
 
 
 
53 
 
PHOTOGRAPH 28.1 
Electrophoresis result showing PVU II digestion 
 
 
PHOTOGRAPH 28.1 
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DISCUSSION 
To date, studies of fluorosis mainly focused on assessing disease prevalence, 
dental, skeletal and non skeletal manifestations of fluorosis, and aesthetic treatment 
modalities of dental fluorosis. There are very few human studies on the genetic 
predisposition to dental fluorosis and very little is known about the role of individual 
genes in determining susceptibility to fluorosis in humans.This study brings some 
needed attention to the potential importance of genetics in determining an individual’s 
vulnerability to dental fluorosis. 
Any individual affected by dental fluorosis above 6 years of age were included 
because dental fluorosis is uncommon in deciduous dentition. This disparity may be 
due to the fact that much of the mineralization of primary teeth occurs before birth and 
the placenta serves as a barrier to the transfer of high concentrations of plasma 
fluoride from a pregnant mother to her developing foetus, thus controlling to a certain 
extent the delivery of fluoride to the developing primary dentition. Other reasons may 
be that the period of enamel formation for primary teeth is shorter than the permanent 
teeth.  
Raymond Dalgleish 
16
 reported that cases presenting with syndromes such as 
Marfan syndrome, Osteogenesis imperfecta and Ehlers–Danlos syndrome, other 
connective tissue disorders and osteoporosis had mutation at the COL1A2 gene. So 
patients with known syndromes, and connective tissue disorders were excluded in the 
present study. Type I collagen is a ubiquitous fibrous protein that provides a major 
part of the tensile strength of bone and several other tissues. Hence, patients with 
history of medication known to affect bone metabolism were excluded from the study. 
Discussion 
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DNA can be isolated from whole blood, saliva, buffy coat, bone material, 
buccal cells, cultured cells, amniotic fluid, sputum, urine, cerebrospinal fluid. 
Although DNA can be isolated from any biological sample, salivary collection is often 
a less invasive procedure, and has lower infection risk, increased patient convenience. 
However, potential disadvantages include lower mean DNA yield and greater 
contamination with DNA of oral bacteria, proteins and food was reported by Philibert 
et al 
47
 Hence in the current study, whole blood sample was chosen. 
Cushwa and Medrano et al 
48
 reported that the optimum storage temperature 
was 4°C for up to a maximum of 4 weeks. Richardson et al 
49
 showed that even 
storage of blood samples at 4
0
 c for up to 2.5 years will yield a viable DNA sample. 
Hence the collected samples were stored at   4
0
 c till DNA isolation. 
According to Suuriniemi M et al 
17
, the  polymorphism in PvuII site of the 
COL1A2 gene was detected by polymerase chain reaction [PCR] followed by 
enzymatic digestion. In this study 771 bp were amplified using the primers as 
specified method in above mentioned study. 
Previously studies were conducted to assess association between genetic 
polymorphism and dental fluorosis among following genes includes Collagen type I 
alpha 2 [COL1A2 gene] PvuII, RsaI
11
, Osteocalcin [OC gene] Hind III
12
, Estrogen 
receptor [ESR gene] RsaI
13
, Parathyroid hormone [PTH gene] Bst BI
14. Among all the 
genes, COL1A2 [PvuII] gene polymorphism was found to be significantly associated 
with susceptibility of dental fluorosis. Collagen 1 alpha 2 (COL1A2) gene play a 
important roles in bone formation and bone architecture, development of the hard 
tissues of the tooth and in turn affects an individual’s susceptibility to dental fluorosis. 
The mechanisms of the underlying relationship between COL1A2 PvuII 
Discussion 
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polymorphisms and dental fluorosis risk are not yet known. Hence in the current study 
COL1A2 gene was chosen to assess the genetic susceptibility to dental fluorosis.
 
 
        The first evidence of an association between polymorphisms in the 
COL1A2 PvuII gene with dental fluorosis in high fluoride exposed populations was 
shown by Huang et al 
11 
. 
The association between PP genotype and dental fluorosis was significantly 
higher[OR = 31.9, 95% CI: 3.9–48.7]   in the current study. The association between 
Pp genotype and dental fluorosis was also substantially higher [OR = 4.0, 95%        
CI: 1.0–10.7] which is not in agreement with previous study on Chinese population by 
Huang et al 
11 
 
              In the present study, the genetic susceptibility had no influence on the 
severity of dental fluorosis, which was relatively similar to a previous study conducted 
by Huang et al 
11 
Previous studies have demonstrated an association between the COL1A2 gene 
and bone development. Suuriniemi M et al
17 
reported that COL1A2 [PVUII] 
polymorphism is associated with non osteoporotic fractures in prepubertal girls. They 
reported that individuals with the homozygous P genotype had higher risk of fracture 
and compared to those with the homozygous p genotype. Willing et al 
50
 also found 
COL1A2 genotypes to have the strongest and most consistent association with bone 
mineral density. The present study also demonstrates similar COL1A2 gene 
polymorphism association with risk of dental fluorosis.  
 
Limitations  
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LIMITATIONS  
1. This present is a hospital based cross sectional study, the exposure and outcome 
were measured simultaneously at one point of time. Thus temporality could not be 
established. 
2. The fluoride exposure of every selected individual could not be accurately 
ascertained in the present study. Rather the fluoride exposure measurement was 
based on the data from fluoride registry averaged for place they lived. 
3. The odds ratio obtained in the present study had less precision due to a wide range 
in 95% confidence interval owing to the relatively smaller sample size and thus 
further research with a larger sample size is needed  
 
Summary and Conclusion 
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SUMMARY AND CONCLUSION 
In conclusion, the present study demonstrated a significant association 
between COL1A2 gene PvuII site polymorphism and the risk of dental fluorosis in a 
high fluoride exposed population. This information may contribute to the 
identification of a subset of the population who may be at risk of developing dental 
fluorosis later in life and may ultimately be of value in planning early preventive 
strategies for dental fluorosis. This suggests that a new biomarker of dental fluorosis 
may be used to identify high-risk populations in areas with high levels of fluoride in 
the drinking water. 
There is a need to replicate these findings in different races. Also, identified 
associations may be different in other populations as there may be functional variants 
in one population that are not present in others. There is also a need to conduct studies 
in regions with various levels of fluoride intake to examine the role of genetic 
background in these populations. 
There is a need to conduct future studies to identify the candidate genes that 
directly, or in interaction with other etiological factors, can alter the risk of dental 
fluorosis. According to principle of high risk approach (Rose 1992), conducting 
genetic studies as a routine test is the best traditional approach for preventing diseases.  
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ANNEXURE –Ia 
 
TAMILNADU GOVT. DENTAL COLLEGE & HOSPITAL CHENNAI -3 
DEPT. OF PUBLIC HEALTH DENTISTRY   
Investigator: Dr. C. Rahila                                                         Guide: Dr. M.B. Aswath Narayanan  
                        
INFORMED CONSENT FORM 
      STUDY TITLE:               
ASSOCIATION BETWEEN COL1A2 PvuII GENE POLYMORPHISM AND SEVERITY OF 
DENTAL FLUOROSIS AMONGST PATIENTS ATTENDING THE  
OUT PATIENT DEPARTMENT OF TNGDCH. 
- A HOSPITAL BASED STUDY 
 
        Name :     Mr/Ms ______________________________              O.P. No.:  
        Address:   ____________________________________               SEX   : Male / Female 
                         ____________________________________                AGE   :            Years                    
                         ____________________________________ 
                ____________________________________ 
 
I, ________________________ , exercising my free power of choice, hereby give my/ for my child 
consent to be included as a participant in the study . 
I agree to the following: 
1. I have been informed to my satisfaction about the purpose of the study and study procedures  
2. I understand that the study involves questions which may sometimes be Personal. 
3. I agree to co-operate fully for complete examination. 
4. I agree to give my/ my child blood sample or any other body fluid of for investigation. 
5. I agree to report to my doctor for a regular follow up as and when required for the research.   
6. I have informed my doctor about all the medications that I am /my child currently taking  
    and other systemic illnesses that I / my child have. 
7. I hereby give permission to use my/my child medical records for research purpose. I am told  
    that the investigating doctor and the institution will keep my/ my child  identity confidential. 
8. I understand that I have rights to withdraw myself /my child from the study and also that  
    the investigator has the right to exclude me/ my child from the research at any point of time. 
 
             
  
 Name                                                   Signature/ Thumb impression of         Date: 
                                                                        Participant/Parent/Guardian 
 
 
 
 Investigator                                                                                                        Date: 
S.NO :   
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      –I-b 
 
   Investigator: ம .  .                                                                                        Guide: ம . ம.  .                   
               
jkpH;;ehL muR gy;; kUj;;Jtf;; fy;;Yhhp kw;;Wk;; kUj;;Jtkid-brd;;id 3 
rKjha gy;; ghJfhg;;g[[ gphpt[[ 
Muha@@r@@rp xg@@g[[jy@@ gotk@ 
Muha@@r@@rp jiyg@@g[[ : ம        .    ம          ம    ம    ம   ;  
               ம                          ம   COL1A2 (PvuII) 
ம                        ; cs;s rk;ge;jj;ij fz;lwpj ;;-    
ம    ம       
 
bgau; :jpU_jpUkjp........................................_                 g[w nehahspapd; vz; ............................... 
Kftup:.............................................................                ghypdk; :  Mz;_ bgz; 
     ..............................................................                 taJ :         ;          
     .............................................................               
ehd; ..........................................._  vd@Dila Raepidt[lDk; kw;Wk; KGRje;jpuj;JlDk; vd;id/           
,k;kUj;Jt Muha@r@rpapy@ nru@j@Jf@ bfhs@s xg@g[jy@ mspf@fpnwd@.  
 
1. ,e@j Muha@r@rpapd@ nehf@fk@ kUj;JtKiwfs@ kw;Wk; gupnrhjid Kiwfs; Fwpj;j tpsf@f'@fs@ midj@Jk@ vdf@F 
jpUg@j@jpjUk@ tifapy@ mspf@fg@gl@ld. 
2. ,e;j Muha;r;rpw;fhf vdJ/           tha; KG ghpnrhjid bra;ag;gLk; vd;gij mwpfpnwd;. 
3. ,e;j Muha;r;rpf;F njitahd KGikahd ghpnrhjidf;F xj;JiHf;f rk;kjpf;fpnwd; 
4. vdJ/           ,uj;j khjphpfisa[k; kw;Wk; gpw jput';fisa[k; ghpnrhjidf;F mspf;f rk;kjpf;fpnwd;. 
5. kUj;Jthpd; Muha;r;rpw;F njitg;gLk;bghGJ kPz;Lk; kUj;Jt Ma;tpw;F fz;og;ghf Muha;r;rpahshplk; tu  
  rk;kjpf;fpnwd;. 
6. ehd; /         Vw;fdnt cl@bfhz@l kw;Wk; cl@bfhs@fpw kUe@Jfisg@ gw;wpa tptu'@fisMuha@r@rpahsuplk@  
  bjuptpj@Js@nsd@. 
7. ve@j xU epiyapYk@ ehd@ ,e@j Muha@r@rpapypUe@J tpyFtjw;Fk@ my@yJ kUj;Jt Muha@r@rpahsUf@F vd@id/    
           tpyf@Ftjw;Fk@ KG cupik  ,Ug@gjhft[k@ mwpfpnwd; 
8. vd; /            kUj;Jtf; Fwpg;ngLfis ,e@j Muha@r@rpapy@ gad@gLj@jpf@bfhs@s rk@kjpf@fpnwd@. ,e@j  
  Muha@r@rp ikaKk@ Muha@r@rpahsUk@ vd@Dila/           tptu'@fs@ midj@ija[k; ,ufrpakhf itg@gjhf  
  mwpfpnwd;. 
9. vdf;F gof;f bjhpahjjhy;/ nkny cs;s midj;ija[k; Twf;nfl;nld;.  
 
       
   
    
     bgau;                                     ifbahg;gk; / ifnuif                    njjp 
                                                  /       /         
      
    
    
    Muha@r@rpahsh;                                 ifbahg;gk                            njjp                                                       
   
thpir vz; :  
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ANNEXURE-IIa 
INFORMATION SHEET 
TAMILNADU GOVT. DENTAL COLLEGE & HOSPITAL CHENNAI -3 
DEPT. OF PUBLIC HEALTH DENTISTRY   
 
Investigator: Dr. C. Rahila                                                Guide: Dr. M.B. Aswath Narayanan  
STUDY TITLE:               
        ASSOCIATION BETWEEN COL1A2 PvuII GENE POLYMORPHISM AND  
SEVERITY OF  DENTAL FLUOROSIS AMONGST PATIENTS ATTENDING THE  
OUT PATIENT DEPARTMENT  OF TNGDCH. 
- A HOSPITAL BASED STUDY 
1. Nature of study: 
The aim of the study is to determine the association between COL1A2 (PvuII) gene 
polymorphism and severity of  dental fluorosis amongst patients attending the outpatient 
department  of TNGDCH. 
  
2. Purpose of Study: 
Fluorosis is an important public health problem in at least 25 countries, including India. 
An estimated 62 million people in India in 17 out of the 32 states are affected with 
fluorosis. Out of these 6 million are children below the age of 14 years. Until recently, 
very few studies have explored the underlying genetic basis for fluoride susceptibility. 
The identification of relatively more susceptible populations may be a means of 
mitigating some of the burden. The study thus will try to find out the association if any 
between both and will suggest methods to prevent the morbidity of dental fluorosis.   
 
3. Duration of Participation: 
The expected duration of participation is 40 minutes with 30 minutes for, Questionnaire 
and assessment of fluoride exposure and severity and 10 minutes for extracting IV. blood. 
There will be no follow up.  
       
4. Procedure: 
A pre validated customized questionnaire will be used where-in questions related to the 
details of fluoride exposure from participants.The severity of the disease will be 
evaluated clinically using Dean’s fluorosis index (1942).and will be duly recorded in a 
case record form. 2 ml of intra venous blood will be drawn from both case and control  
and will be stored for genetic analysis. 
  
5. Associated risks: 
This research will be conducted with necessary precautions by a registered dental 
surgeon, the risks associated with the procedure are minimal.  
 
S.NO :   
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6. Riskmanagement:                                                                                                                                   
In case of any emergency, management of the same will be carried out at the same 
hospital itself.  
 
7.  Benefits: 
To the Participants: 
This study helps the participants in understanding the importance of genetics in 
determining  his/her vulnerability to fluorosis and also enable him to take precautions for 
his family members. After the assessment the participants would be referred to provide 
aesthetic improvement. 
To the community: 
A new biomarker of dental fluorosis may be used to identify high-risk populations in 
areas with high levels of fluoride in the drinking water.  
To the Medical Profession: 
Association if proven the study will be an  approach developed for fluorosis mitigation. 
This will enable the medical professional in his/ her efforts towards preventing this 
morbid disease. 
 
8. Confidentiality: 
Each participant will be assigned a serial number and their records will be maintained 
throughout the study as highly confidential. In the event of any publication or 
presentation resulting from the research, no personal identifiable information will be 
shared.  
 
 
9. Voluntary participation: 
Taking part in this study is voluntary. No Compensation will be given for travel expenses 
for follow up trip. You are free to decide whether to participate or to withdraw at any 
time; Your decision will not  result in any loss of benefits to which you are otherwise 
entitled. 
   
10. Contact details of Chairman of IEC:  
              Dr. S.Premkumar. Principal, Tamil Nadu Government Dental College, Chennai. 
 
 Signature of the investigator:                                                   Signature/Thumb impression of the  
                                                                                                            Participant/Parent/Guardian 
                                                                      
 Date:          
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      – II-b 
Muha;r;rp gw;wpa jfty; gotk; 
 
   Investigator: ம .  .                                            Guide: ம . ம.  .           ; 
 
jkpH;;ehL muR gy;; kUj;;Jtf;; fy;;Yhhp kw;;Wk;; kUj;;Jtkid-brd;;id 3 
rKjha gy;; ghJfhg;;g[[ gphpt[[ 
 
Muha@@r@@rp jiyg@@ ;; :  ம        .    ம          ம    
ம    ம   ;                 ம                  
        ம   COL1A2 (PvuII) ம                        ; 
cs;s rk;ge;jj;ij  fz;lwpj ;;-    ம    ம       
 
1.Muha;r;rp   :   ம 
 ம        .    ம          ம    ம    ம   ;;                 ம      
                    ம   COL1A2 (PvuII) ம                        ; 
cs;s rk;ge;jj;ij  fz;lwp       
 
2.Muha;r;rpapd; nehf;fk;  
                           25       ,        ம               
               .  32 ம        17            ம         62 ம     ம    
                           .     6 ம     14               
               . 
 ம                                ம        ம             
         .                       ம             ம              
                . Mdhy; nkw;go Ma;thdJ          FiwghLfs; kw;Wk; 
mjw;fhd jLg;g[ Kiwfs; fz;lwpa              bra;ag;gLfpwJ. 
 
3.g';fspg;g[ neuk;                                                                             
nehahsp;apd; g';fspg;g[ neuk; 40 epkplj;jpw;F nkw;glhJ. me;j 40 epkplj;jpy; 30 epkplk; 
nehahsp;apd; jfty; nrfhpg;gpw;Fk; mLj;j 10  epkplk; ,uj;j ghpnrhjidf;fhft[k; 
xJf;fg;gLfpwJ.  
 
4.rpfpr;ir Kiw 
.Kiwg;gLj;jg;gl;l jfty; mwpf;if      ;          \yk ghjpj;j kw;Wk; 
ghjpf;fg;glhj               ,f;Fiwghl;il Vw;gLj;Jk; fhuzpfis gw;wpa nfs;tpfs; 
nfl;fg;gLk;. Fiwghl;od; tPwpaj;ij fz;lwpe;J jfty; mwpf;ifapy;  
thpir vz; :  
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nrh;f;fg;gLk;..Xt;bthU             kpUe;J 2kpy;yp ypl;lh; ,uj;jk; vLj;J kugD 
ghpnrhjidf;fhf nrfhpf;fg;gLk;. 
5.gf;ftpist[fs;                                                              
,e;j Muha;r;rp ed;F gapw;rp bgw;w gy; kUj;Jtuhy; mspf;fgLfpwJ. Mjyhy; ve;j tpj 
ghjpg;g[k; Vw;gl tha;g;g[ ,y;iy .                                                                                   
6.mtrurpfpr;ir                                                                      
xU ntis mtru rpfpr;ir njitg;gLk; gl;rj;jpy; mnj kUj;Jtkizay; 
rpfpr;iraspf;fg;gLk;. 
7.Muha;r;rpapd; gad;fs; 
g';fspg;nghUf;F                                                                   
        ம                            ம                        
                    .  ம                                    
          
r\fj;jpw;F                                                                         
COL1A2 ம                         -                             
                    ம  is                        .  
8.jfty; ,ufrpak;                                                     
fye;Jf;bfhs;Sk; neha}spfSf;F thpir vz; jug;gLk; kw;Wk; mth;fspd; Fwpg;g[fs; 
Muha;r;rp Koa[k; tiu gpwu; mwpahtz;zk; ,ufrpakhf ghJfhf;fg;gLk;. mij btspapLk; 
neuj;jpy; ve;j nehahspapd; jdp milahs';fSk; btspapl glkhl;lhJ . 
 
9.jdpr;irapy;yhj g';nfw;wy; 
,e;j Muha;r;rpapy; g';F bgWtJ c';fspd; jdpg;gl;l KothFk;. ,J nehahspfs; 
jhdhfnt g';fspf;Fk; gl;rj;jpy;  gazg;gpo jug;glhJ. ,e;j Muha;r;rpapypUe;J eP';fs; 
vg;bghGJ ntz;LkhdhYk; tpyfpf; bfhs;syhk;. ,J c';fSf;nfh my;yJ 
Muha;r;rpahsUf;nfh ve;jtpj ghjpg;g[k; Vw;gLj;jhJ vd;gij  bjhpag;gLj;Jfpnwhk;. 
 
10.Kjy;th; [ Muha;rrp mDkjp fHfk; : 
   lhf;lh;  S.      ம    
   Kjy;th; 
   jkpH;ehL muR gy; kUj;Jtf; fy;Yhhp kw;Wk; kUj;Jtkiz [ brd;id - 3 
 
 
 
 
 
Muha;r;rpahsh; ifbahg;gk;                 ifbahg;gk; / ifnuif 
                                                                           /       /         
                                    
 
 
njjp: :::::     
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ANNEXURE – III 
 
TAMIL NADU GOVT. DENTAL COLLEGE & HOSPITAL CHENNAI – 3 
DEPT. OF PUBLIC HEALTH DENTISTRY 
 
Investigator: Dr. C.Rahila                                        Guide: Dr. M.B. Aswath Narayanan 
              
TITLE:  
ASSOCIATION BETWEEN COL1A2 (PvuII) GENE POLYMORPHISM AND SEVERITY OF  
DENTAL FLUOROSIS AMONGST PATIENTS ATTENDING THE 
OUT PATIENT DEPARTMENT  OF TNGDCH. 
- A HOSPITAL BASED STUDY 
 
QUESTIONNAIRE 
I. Demographic data: 
1. Name: Mr/Mrs.       
2. Age:   (Years) 
3. Sex: 
4. Date of Birth:       /       /        
5. Place of Birth: 
6. Address: 
 
 
7. Area of Residence:   1. Rural      2. Urban  3.Periurban 
8. Religion: Hindu/ Muslim/ Christian/ Sikh/ Buddhist/ Jain/ others specify 
9. Educational Qualification: 
    a. Profession or Honours  
    b. Graduate or post graduate  
    c. Intermediate or post high school diploma  
    d. High school certificate  
    e. Middle school certificate  
    f. Primary school certificate  
    g. Illiterate 
10. Occupation:  
     a. Profession  
     b. Semi-Profession  
     c. Clerical, Shop-owner, Farmer  
     d. Skilled worker  
     e. Semi-skilled worker  
     f. Unskilled worker 
11. Marital Status:  
     a. Unmarried   
     b. Married   
     c. Widowed  
     d. Divorced  
12. Individual Income (per month): .  
13. Per capita Income:  .              / Person              
 
II . Family History: 
A. Do your parents  have dental fluorosis? 
     a. Father:  Yes/ No/ Don’t know 
     b. Mother: Yes/ No/ Don’t know 
B. How many siblings do you have?  
S.NO: 
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     a. 1     b. 2     c. 3    d. 4   
i). Do they have dental fluorosis? 
     a. 1- Yes/ No/ Don’t know 
          b. 2- Yes/ No/ Don’t know  
            c. 3- Yes/ No/ Don’t know  
              d. 4- Yes/ No/ Don’t know 
C. How many children do you have?  
     a. 1     b. 2     c. 3    d. 4   
 i).  Do they have dental fluorosis? 
 a. 1- Yes/ No/ Don’t know 
 b. 2- Yes/ No/ Don’t know  
 c. 3- Yes/ No/ Don’t know  
 d. 4- Yes/ No/ Don’t know 
 
III.Personal History 
 1. Details of Tobacco Use: 
Type 
 
Age 
of 
Onset 
Average No. 
of cigs/ bidis/ 
sachets used 
per day 
No. of years 
of Regular 
Tobacco use 
Sachet/ Cigarette years 
(No. of cigs. Bidis/ sachets 
used per day X No. of 
years of regular tobacco 
used) 
Average number of 
cigarettes/ sachets, 
amount of tobacco 
chewed per day in 
the last one month 
Smoking 
1. 
2. 
3. 
     
Smokeless 
1. 
2. 
3. 
     
2. Details of Alcohol Usage 
A.  Do you consume Alcohol? 
      a. Yes 
      b. No 
B.  Alcohol usage (pattern) 
      a. Daily Drinking 
      b. Regular Drinking (3 or more times/week) 
      c. Social Drinking (<3times week) 
      d. None  
 
IV.Diet History 
 I. Type of diet  
    a) Vegan diet   b) Lacto vegetarian diet       c) Lacto ovo vegetarian diet       d)Mixed diet 
  
V. Medical History: 
Cardiovascular System: 
a. Angina 
b. Myocardial Infarction 
c. Arterial disease  
d. Hypertension 
e. Valvular Heart disease 
f. Congenital Heart Disease 
g. Disorders of Heart rate, Rhythm and conduction  
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Respiratory System: 
a. Diseases of Nasopharynx 
b. Diseases of Larynx 
c. Tracheal Disorders 
d. Asthma  
e. COPD  
f. Bronchiectasis 
g. Lung Infections  
Central Nervous System: 
a. Headache  
b. Facial Pain 
c. Vertigo  
d. Epilepsy 
e. Cerebrovascular Disease (including Stroke) 
f. Neurological Disorders  
g. Cervical Spondylosis  
Gastro-Instestinal System: 
a. Gastritis/Acid Peptic Disease  
b. Irritable Bowel Disease   
c. Inflammatory Bowel Disease 
d. Reflux oesophagitis 
e. Constipation 
f. Pain in stomach 
g. Loss of appetite 
Endocrine System: 
a. Diabetes Mellitus 
b. Hypothyroidism  
c. Hyperthyroidism 
d. Hyperparathyroidism  
e. Hypoparathyroidism / Tetany  
f. Addison’s Disease  
g. Cushing’s Disease 
h. Disorders of pituitary gland (including Acromegaly) 
i. Menstrual Abnormalities  
Uro-genital System 
a. Renal Disorders 
b. Urinary Tract Infections 
Blood: 
a. Anemia 
b. Bleeding Disorders 
c. Venous Thrombosis 
Diseases of Bone and Joints: 
a. Osteoporosis 
b. Osteomalacia and Rickets 
c. Pagets Disease 
d. Primary Bone Disease 
e. Rheumatoid Arthritis  
f. Bone and Joint infection  
Miscellaneous:  
a. History of Trauma and Accidents  
b. Recent Hospitalization  
VI. Obsteric History 
 a. Pregnancy/ Lactation: 
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 b.  History of any abortion/ still births/ Low birth weight?               Yes/No 
 
 
VII. Nutritional status 
 BMI (Quetlet index) (Kg/m
2
): 
                                a. Height  : 
                                b. Weight : 
 
 
 
 
VIII.Drug History:  
 DRUG DOSAGE FREQUENCY DURATION 
Anti Coagulants 
 Acenocoumarol    
 Dicoumarol    
 Warfarin sodium    
 Ethylbiscoum acetate    
Anti Platelet Drugs 
 Aspirin    
 Clopidogrel    
 Dipyridamole    
 Ticlopidine    
 Abciximab    
Nutritional   supplements 
 Ferrous sulfate    
 Bct    
 Mvt    
 Ascorbic acid    
 Calcium  preparations    
 Vit e     
 Vit c    
 Vit k    
 Fluoride    
 1,25-dihydroxyvitamin d3     
Hormone Replacement Therapy 
 Calcitonin    
 Parathyroid hormone     
 Bisphosphonates    
IX.Flouride Exposure 
1. Place of your residence in 0-12 yrs? 
1 Chennai 9 Madurai 17 Virudhunagar 25 Ramanathapuram 
2 Kancheepuram 10 Tiruchirappalli 18 Krishnagiri 26 Sivaganga 
3 Vellore 11 Cuddalore 19 Kanniyakumari 27 Thiruvarur 
4 Thiruvallur 12 Tiruppur 20 Thoothukkudi 28 Theni 
5 Salem 13 Tiruvannamalai 21 Namakkal  29 Karur 
6 Viluppuram 14 Thanjavur 22 Pudukkottai 30 Ariyalur 
7 Coimbatore 15 Erode 23 Nagapattinam 31 The Nilgiris 
8 Tirunelveli 16 Dindigul 24 Dharmapuri 32 Perambalur 
2. What is your place of stay in  following  duration of period?  
     a) from birth - 1 year  - 
     b) from 2years -5years- 
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     c) from5 years – 8 years - 
     d) from 8 years- to till now- 
3.  Source of water:  
A. What is the source of your drinking water?  
     a) Lake             b) Pond                 c) River                 d) Well                   e) Bore well   
     f) Corporation Piped water            g) packaged water  
B. How often do you drink water?  
     a) 1-3 times per day b) 4-7 times per day  c) 8-10 times per day  
     d) more than 10 times per day. 
C. For cooking purpose, which source of water do you use?  
     a) Lake             b) Pond                 c) River                 d) Well                   e) Bore well   
     f) Corporation Piped water            g) packaged water  
 
D. Is there any industrial plant nearby your residence? 
     a) None         b)Phosphate Fertilizer Plant          c)Pesticide plant        d) Cement Plant  
     e) Chemical Plant            f)Electroplate plant     g) Other plant           h) Don’t know 
 
X. FLUOROSIS 
1. Dental fluorosis : Yes / No 
Severity of Dental fluorosis 
DEAN’S FLUOROSIS INDEX 
AUTHOR : TRENDLEY. H. DEAN                                                                                 YEAR : 1942 
 
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
                
                
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
 
             SCORE _______ INFERENCE____________ 
Scoring criteria 
CLASSIFICATION  CRITERIA  
NORMAL (0)  Normal  
QUESTIONABLE (0.5)  Normal translucency is varied by a few white flecks or white spots  
VERY MILD (1)  Small,opaque paper white areas are scattered over the teeth,involving less than 25% 
of the surface  
MILD (2)  White opaque areas are more extensive but do not involve more than 50% of the 
surface  
MODERATE (3)  All enamel surface are affected and those subject to attrition show marked 
wear.Brown stain is a frequent disfiguring feature  
SEVERE (4)  All enamel surface are affected and hypoplasia is so marked that tooth form may be 
altered. A major diagnostic sign is discrete or confluent pitting. Brown stains are 
widespread and the teeth often present a corroded appearance  
3.Skeletal fluorosis:                                                 Yes/ No 
    Manifestations of  non Skeletal fluorosis 
       a. Pain in bones and joints,  
       b. Osteoporosis in bones of the extremities,  
       c. Stiffness of joints and chronic fatigue 
       d. Restriction of the spine movements 
       e. Paralysis 
4. Manifestations of  non Skeletal fluorosis:  
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a. Neurological manifestations like depression, nervousness, headache 
b. Gastrointestinal problems, nausea, abdominal pain, diarrhea, blood in stools 
c. Muscular manifestations like muscle  weakness, pain in muscle 
d. Allergic manifestations like  skin rashes  
e. Urinary tract manifestations like decreased volume of urine, colour change in urine. 
f. Burning, prickling, and tingling in limbs. 
XI. Genetic  analysis: 
1. Date of  blood collection: 
2. Date of sending blood for analysis:  
Association between COL1A2 (PvuII) Gene Polymorphism and severity of  Dental fluorosis: 
COL1A2 (PvuII) Gene 
Polymorphism 
Severity of  Dental 
fluorosis 
Yes/ No 
PP   
Pp   
pp   
 
